Fractionation of immune RNA capable of transferring tumor-specific cellular cytotoxicity

Abstract

Xenogeneic immune RNA (I-RNA) extracted from the spleens and lymph nodes of guinea pigs previously immunized with a murine fibrosarcoma was able to convert normal mouse lymphocytes to effector cells specifically cytolytic to the same murine tumor in vitro. This effect of I-RNA was dose-dependent, and destroyed by treatment with RNase, but not with DNase or pronase. I-RNA was fractionated by ultracentrifugation on a 5–20% sucrose density gradient and the fraction capable of transferring cell-mediated cytotoxicity (CMC) was shown to have a sedimentation coefficient of 8–16 S. I-RNA was also fractionated by oligo(dT)-cellulose affinity chromatography and the active fraction was found to possess polyadenylic acid (poly(A)) sequences thus resembling messenger RNA. The immunological activity of the poly (A)-containing RNA fraction was tumor-specific and RNase-sensitive. In further experiments, I-RNA fractionated by sucrose density gradient ultracentrifugation was subsequently chromatographed. on an oligo(dT)-cellulose column. CMC was transferred only by the fraction which sedimented at 8–16 S and also contained poly (A).